Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults
Authors not listed
The University of Texas Health Science Center at San Antonio · 2026
Abstract
Obesity and type 2 diabetes mellitus (T2DM) represent major public health concerns in the aging community. Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist recently approved for the treatment of T2DM and obesity has been shown to be effective at reducing weight, improving markers of T2DM control, and improving cardiovascular health. Utilization of tirzepatide among older adults has been on the rise since FDA approval was issued, however the effects of tirzepatide use on functional outcomes in older adults with obesity are not well established. Recent studies show that weight loss caused by tirzepatide may be driven by substantial loss of lean muscle mass, which may contribute to weakness and frailty, particularly among older adults. The proposed pilot study aims to evaluate how treatment with tirzepatide for 6 months affects muscle mass and function among older adults, and if changes in muscle mass are linked to changes in functional status over the same time period.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2026). The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults. <em>The University of Texas Health Science Center at San Antonio</em>. https://clinicaltrials.gov/study/NCT06811324
Vancouver
Anonymous. The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults. The University of Texas Health Science Center at San Antonio. 2026.
BibTeX
@misc{anon2026TheEff,
title = {The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults},
author = {Anonymous},
journal = {The University of Texas Health Science Center at San Antonio},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
The University of Texas at San Antonio 2017
Open access · US-GOV
Egg Protein Supplementation for Maintaining Muscle Mass and Function in Older Adults
Brigham and Women's Hospital 2021
Open access · US-GOV
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
yueh chu wu 2026
Open access · US-GOV
Effects of Multimodal Training on Muscle Function and Glucose Metabolism in Middle-Aged and Older Adults With Type 2 Diabetes Mellitus and Sarcopenia
Nature Aging 2022
Open access · OA
Associations of the skin, oral and gut microbiome with aging, frailty and infection risk reservoirs in older adults
National Cheng-Kung University Hospital 2023
Open access · US-GOV